IPQ Inside the global regulatory dialogue

EMA Process Validation Draft Targets Filing Requirements and Assessor Needs

May 30th, 2012

Please Log in to print the full article

The European Medicines Agency (EMA) has released a draft process validation (PV) guideline that mirrors FDA’s PV guide in principle, but is aimed more at the content and assessment of marketing authorization applications rather than...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications